Regulatory coding of lymphoid lineage choice by hematopoietic transcription factors

Current Opinion in Immunology

Volumn 15, Issue 2, 2003, Pages 166-175

  Warren, Luigi A ^a   Rothenberg, Ellen V ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1;

AGONIST; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL STRUCTURE; CELLULAR IMMUNITY; DENDRITIC CELL; EXPERIMENTAL TEST; GENE EXPRESSION; HEMATOPOIETIC SYSTEM; IMMUNOLOGY; LYMPHOID CELL; NATURAL KILLER CELL; NONHUMAN; REGULATORY MECHANISM; REVIEW; STEM CELL; T LYMPHOCYTE; THYMOCYTE; THYMUS;

NASA DISCIPLINE EVOLUTIONARY BIOLOGY; NASA PROGRAM FUNDAMENTAL SPACE BIOLOGY; NON-NASA CENTER;

EID: 0037375763     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00011-6     Document Type: Review

References (90)

1. Schebesta M., Pfeffer P.L., Busslinger M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity. 17:2002;473-485.
2. Schebesta M., Heavey B., Busslinger M. Transcriptional control of B-cell development. Curr. Opin. Immunol. 14:2002;216-223.
3. Quong M.W., Romanow W.J., Murre C. E protein function in lymphocyte development. Annu. Rev. Immunol. 20:2002;301-322.
4. DeKoter R.P., Lee H.-J., Singh H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity. 16:2002;297-309 Hematopoietic progenitors recovered from PU.1-null mutant embryos do not express the lymphoid cytokine receptor gene IL-7Rα. Both PU.1 and IL-7Rα transgenes rescue B-lineage differentiation, which is normally abrogated in these mutants, PU.1 being more effective in this regard than IL-7Rα. Chromatin immunoprecipitation (ChIP) assays revealed that PU.1 binds directly to the IL-7Rα promoter. It therefore appears that PU.1 promotes early B-lineage development in large part by facilitating IL-7 signal transduction.
5. Gisler R., Sigvardsson M. The human V-preB promoter is a target for coordinated activation by early B cell factor and E47. J. Immunol. 168:2002;5130-5138.
6. Sigvardsson M., O'Riordan M., Grosschedl R. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity. 7:1997;25-36.
7. Garvie C.W., Hagman J., Wolberger C. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell. 8:2001;1267-1276.
8. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:2000;193-197.
9. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:1997;661-672.
10. ••]).
11. ••]).
12. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., Enver T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11:1997;774-785.
13. ••]).
14. Delassus S., Titley I., Enver T. Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. Blood. 94:1999;1495-1503.
15. Miyamoto T., Iwasaki H., Reizis B., Ye M., Graf T., Weissman I.L., Akashi K. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev. Cell. 3:2002;137-147 Inspired by the approach of [12], this paper uses powerful single-cell gene expression analyses to prove that individual cells of the CLP and CMP classes are generally lymphoid- or myeloid-restricted in their gene expression profiles, respectively. The authors also show that individual cells of the CLP and CMP classes simultaneously express sets of genes that are normally associated with mutually exclusive developmental fates in their descendants, albeit at levels approximately an order of magnitude below those characteristic of legitimate expression in committed cell types. CLPs coexpress genes that are both T- and B-cell specific, and CMPs coexpress genes that are both myeloid- and erythroid-specific. However, although HSCs promiscuously express a broad spectrum of hematopoietic lineage genes, they are largely devoid of lymphoid expression, perhaps reflecting the late emergence of lymphopoiesis in evolution. Considerable heterogeneity in gene expression profiles was also noted within each class of cells. Given the snapshot-like nature of the assay, these variations could represent either fluctuating levels in individual cells or a distribution of stable expression patterns. The findings suggest that multipotency is sometimes mediated by coexpression of competing lineage programs at intermediate or 'floating' levels as a prelude to exclusive, winner-takes-all commitment.
16. ••].
17. ••] are capable of differentiating into T, B, or NK cells, although in each case repression as well as activation of genes is seen with particular cell fates. This body of work emphasizes the regulatory instability of the intermediate states between hematopoietic stem cells and committed lymphoid precursors.
18. Davidson E.H., Rast J.P., Oliveri P., Ransick A., Calestani C., Yuh C.-H., Minokawa T., Amore G., Hinman V., Arenas-Mena C.et al. A provisional regulatory gene network for specification of endomesoderm in the sea urchin embryo. Devel. Biol. 246:2002;162-190.
19. Davidson E.H., Rast J.P., Oliveri P., Ransick A., Calestani C., Yuh C.H., Minokawa T., Amore G., Hinman V., Arenas-Mena C.et al. A genomic regulatory network for development. Science. 295:2002;1669-1678 This is the first multilineage developmental system to be solved by genomic regulatory network analysis based on empirical perturbation studies, and is a potential model for approaches to analysis of hematopoietic developmental choices. This is the most accessible presentation of this work to a general audience.
20. Tumpel S., Maconochie M., Wiedemann L.M., Krumlauf R. Conservation and diversity in the cis-regulatory networks that integrate information controlling expression of Hoxa2 in hindbrain and cranial neural crest cells in vertebrates. Dev. Biol. 246:2002;45-56.
21. Dasen J.S., Rosenfeld M.G. Combinatorial codes in signaling and synergy: lessons from pituitary development. Curr. Opin. Genet. Dev. 9:1999;566-574.
22. Lloberas J., Soler C., Celada A. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol. Today. 20:1999;184-189.
23. Fisher R.C., Scott E.W. Role of PU.1 in hematopoiesis. Stem Cells. 16:1998;25-37.
24. ••,29]. The definition of the developmental window for PU.1 effects here correlates with in vivo regulation of PU.1 in normal pro-T cells, and links the perturbation to in vivo developmental plasticity. The effects of PU.1 misexpression on the pattern of gene expression in a pro-T-like cell line are shown to be governed by bistable switch-like behavior that implicates additional network functions in the response.
25. Yamada T., Abe M., Higashi T., Yamamoto H., Kihara-Negishi F., Sakurai T., Shirai T., Oikawa T. Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells. Blood. 97:2001;2300-2307.
26. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
27. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
28. Spain L.M., Guerriero A., Kunjibettu S., Scott E.W. T cell development in PU.1-deficient mice. J. Immunol. 163:1999;2681-2687.
29. DeKoter R.P., Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 288:2000;1439-1441.
30. Berg L.J., Kang J. Molecular determinants of TCR expression and selection. Curr. Opin. Immunol. 13:2001;232-241.
31. Colucci F., Samson S.I., DeKoter R.P., Lantz O., Singh H., Di Santo J.P. Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood. 97:2001;2625-2632.
32. Cantor A.B., Orkin S.H. Hematopoietic development: a balancing act. Curr. Opin. Genet. Dev. 11:2001;513-519.
33. Graf T: Transcription factors that induce commitment of multipotent hematopoietic progenitors: lessons from the MEP system. In Hematopoiesis: a Developmental Approach. Edited by Zon LI. New York: Oxford University Press; 2001:355-362.
34. Nerlov C, Tenen DG, Graf T: Regulatory interactions between transcription factors and their role in hematopoietic lineage determination. In Hematopoiesis: a Developmental Approach. Edited by Zon LI. New York: Oxford University Press; 2001:363-367.
35. Hong W., Kim A.Y., Ky S., Rakowski C., Seo S.-B., Chakravarti D., Atchison M., Blobel G.A. Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1. Mol. Cell. Biol. 22:2002;3729-3743 This paper describes a mechanism through which PU.1 can antagonize GATA-1 activity by interference with its acetylation. Even if this should not turn out to be the major mechanism for PU.1/GATA antagonism, it could be significant as a way for PU.1 to selectively antagonize acetylation-dependent functions of GATA factors while permitting their acetylation-independent functions [36]. This mechanism could contribute to the combinatorial regulatory potential for intermediate states in which both PU.1 and GATA factors are expressed.
36. Yamagata T., Mitani K., Oda H., Suzuki T., Honda H., Asai T., Maki K., Nakamoto T., Hirai H. Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organs. EMBO J. 19:2000;4676-4687.
37. Chen H., Ray-Gallet D., Zhang P., Hetherington C.J., Gonzalez D.A., Zhang D.E., Moreau-Gachelin F., Tenen D.G. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene. 11:1995;1549-1560.
38. Seshasayee D., Gaines P., Wojchowski D.M. GATA-1 dominantly activates a program of erythroid gene expression in factor-dependent myeloid FDCW2 cells. Mol. Cell. Biol. 18:1998;3278-3288.
39. Tsai S.F., Strauss E., Orkin S.H. Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. Genes Dev. 5:1991;919-931.
40. Anderson K.P., Crable S.C., Lingrel J.B. The GATA-E box-GATA motif in the EKLF promoter is required for in vivo expression. Blood. 95:2000;1652-1655.
41. Nerlov C., Graf T. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12:1998;2403-2412.
42. Dahl R., Ramirez-Bergeron D.L., Rao S., Simon M.C. Spi-B can functionally replace PU.1 in myeloid but not lymphoid development. EMBO J. 21:2002;2220-2230 This paper uses a knock-in system to test the interchangeability of Spi-B and PU.1. The results emphasize the key role of PU.1 and/or the perfect regulation of PU.1 levels to generate lymphoid lineages.
43. Chen D., Zhang G. Enforced expression of the GATA-3 transcription factor affects cell fate decisions in hematopoiesis. Exp. Hematol. 29:2001;971-980.
44. Weiss M.J., Keller G., Orkin S.H. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1-embryonic stem cells. Genes Dev. 8:1994;1184-1197.
45. Walsh J.C., DeKoter R.P., Lee H.J., Smith E.D., Lancki D.W., Gurish M.F., Friend D.S., Stevens R.L., Anastasi J., Singh H. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity. 17:2002;665-676.
46. ••]. An extensive analysis of gene expression alterations in T-cell precursors under perturbation with GATA-3 and PU.1 leads to the assembly of the first draft assembly of regulatory network elements for T-cell specification.
47. Georgopoulos K. Transcription factors required for lymphoid lineage commitment. Curr. Opin. Immunol. 9:1997;222-227.
48. Brown K.E., Guest S.S., Smale S.T., Hahm K., Merkenschlager M., Fisher A.G. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell. 91:1997;845-854.
49. Mikkola I., Heavey B., Horcher M., Busslinger M. Reversion of B cell commitment upon loss of Pax5 expression. Science. 297:2002;110-113 This paper formally proves that normal precursors undergoing B-cell specification cannot become committed without sustained expression of the lock-down functions provided by Pax5.
50. Busslinger M., Nutt S.L., Rolink A.G. Lineage commitment in lymphopoiesis. Curr. Opin. Immunol. 12:2000;151-158.
51. Herblot S., Steff A.M., Hugo P., Aplan P.D., Hoang T. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression. Nat. Immunol. 1:2000;138-144.
52. Anderson M.K., Hernandez-Hoyos G., Diamond R.A., Rothenberg E.V. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development. 126:1999;3131-3148.
53. Varnum-Finney B., Xu L., Brashem-Stein C., Nourigat C., Flowers D., Bakkour S., Pear W.S., Bernstein I.D. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6:2000;1278-1281.
54. Allman D., Punt J.A., Izon D.J., Aster J.C., Pear W.S. An invitation to T and more: notch signaling in lymphopoiesis. Cell. 109(Suppl):2002;S1-S11.
55. Borowski C., Martin C., Gounari F., Haughn L., Aifantis I., Grassi F., von Boehmer H. On the brink of becoming a T cell. Curr. Opin. Immunol. 14:2002;200-206.
56. MacDonald H.R., Wilson A., Radtke F. Notch1 and T-cell development: insights from conditional knockout mice. Trends Immunol. 22:2001;155-160.
57. Allman D., Karnell F.G., Punt J.A., Bakkour S., Xu L., Myung P., Koretzky G.A., Pui J.C., Aster J.C., Pear W.S. Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J. Exp. Med. 194:2001;99-106.
58. De Smedt M., Reynvoet K., Kerre T., Taghon T., Verhasselt B., Vandekerckhove B., Leclercq G., Plum J. Active form of Notch imposes T cell fate in human progenitor cells. J. Immunol. 169:2002;3021-3029 This reference presents an in vitro culture system in which hematopoietic precursors can be isolated and shown to differentiate into T/NK precursors when transduced with activated Notch, losing B-cell differentiation activity. This confirms and extends earlier results from whole animal studies and culture systems that do not permit the direct determination of T-lineage potential [59-63].
59. Jaleco A.C., Neves H., Hooijberg E., Gameiro P., Clode N., Haury M., Henrique D., Parreira L. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J. Exp. Med. 194:2001;991-1002.
60. Pui J.C., Allman D., Xu L., DeRocco S., Karnell F.G., Bakkour S., Lee J.Y., Kadesch T., Hardy R.R., Aster J.C., Pear W.S. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 11:1999;299-308.
61. Koch U., Lacombe T.A., Holland D., Bowman J.L., Cohen B.L., Egan S.E., Guidos C.J. Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. Immunity. 15:2001;225-236.
62. Radtke F., Wilson A., Stark G., Bauer M., van Meerwijk J., MacDonald H.R., Aguet M. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 10:1999;547-558.
63. Wilson A., MacDonald H.R., Radtke F. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194:2001;1003-1012.
64. Cheng P., Zlobin A., Volgina V., Gottipati S., Osborne B., Simel E.J., Miele L., Gabrilovich D.I. Notch-1 regulates NF-κB activity in hemopoietic progenitor cells. J. Immunol. 167:2001;4458-4467.
65. Han H., Tanigaki K., Yamamoto N., Kuroda K., Yoshimoto M., Nakahata T., Ikuta K., Honjo T. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14:2002;637-645 Using a conditional knockout, the authors showed that CSL is essential for early T-cell differentiation in the thymus. The knockout also had the effect of inducing B lymphopoiesis in the thymus, again recapitulating the effects of a Notch knockout and supporting the central role of the CSL-Notch-ICN complex in regulating the B versus T lineage choice.
66. Reizis B., Leder P. Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway. Genes Dev. 16:2002;295-300 The first demonstration of a pathway through which a T-lineage-associated gene is directly regulated by Notch-CSL in the earliest stages of T-lineage specification. The initial onset of pTα expression is shown to depend on the CSL site in its cis-regulatory region for correct timing.
67. von Boehmer H., Aifantis I., Feinberg J., Lechner O., Saint-Ruf C., Walter U., Buer J., Azogui O. Pleiotropic changes controlled by the pre-T-cell receptor. Curr. Opin. Immunol. 11:1999;135-142.
68. Tomita K., Hattori M., Nakamura E., Nakanishi S., Minato N., Kageyama R. The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev. 13:1999;1203-1210.
69. Kawamata S., Du C., Li K., Lavau C. Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene. 21:2002;3855-3863 HES genes encode bHLH transcription factors that can act as repressors. HES-1 and HES-5 are directly upregulated by Notch via the CSL (here called CBF1) pathway. Transplantation of transgenic mouse bone-marrow tissue expressing either Hes family genes or Notch-ICN showed that, although constitutive Notch signaling leads to a complete block in B-lineage development, overexpression of HES-1 or HES-5 can produce a partial block. In a reporter gene assay, NotchIC, HES-1 and HES-5 (but not HES-2 or HES-3) were found to inhibit the transactivation potential of E2A, an E protein that plays a key role in B-lineage commitment. These experiments suggest that Notch could suppress the B-lineage fate in part through HES-mediated repression of the E2A gene.
70. Zhuang Y., Barndt R.J., Pan L., Kelley R., Dai M. Functional replacement of the mouse E2A gene with a human HEB cDNA. Mol. Cell. Biol. 18:1998;3340-3349.
71. Radtke F., Ferrero I., Wilson A., Lees R., Aguet M., MacDonald H.R. Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J. Exp. Med. 191:2000;1085-1094.
72. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S., Gruss P. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 397:1999;702-706.
73. Ikawa T., Fujimoto S., Kawamoto H., Katsura Y., Yokota Y. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA. 98:2001;5164-5169 This paper presents a comparison of hematopoietic cells recovered from the fetal thymus of wild-type and Id2-null mice, which revealed a sharp reduction in the number of cells expressing the NK cell marker CD122 (IL-2R) in the mutants. Overall thymocyte cellularity was about the same for mutant and wild type, which suggests that thymically-localized hematopoietic progenitors simply follow the T-lineage program in the absence of Id2. Buttressing this inference, Id2-null fetal thymic organ culture (FTOC) failed to produce mature NK cells but exhibited normal T-cell development, whereas RT-PCR analysis of wild-type progenitors fractionated on the basis of CD122 expression revealed a strong correlation between Id2 levels and NK-lineage commitment.
74. Kee B.L., Bain G., Murre C. IL-7Rα and E47: independent pathways required for development of multipotent lymphoid progenitors. EMBO J. 21:2002;103-113 This paper shows that the pathways regulating IL-7Rα expression and the pathways dependent on E47 are not redundant but complementary in promoting the survival of T-lymphoid progenitors through the earliest stages of their development.
75. Petersson K., Ivars F., Sigvardsson M. The pTα promoter and enhancer are direct targets for transactivation by E box-binding proteins. Eur. J. Immunol. 32:2002;911-920.
76. Rosmaraki E.E., Douagi I., Roth C., Colucci F., Cumano A., Di Santo J.P. Identification of committed NK cell progenitors in adult murine bone marrow. Eur. J. Immunol. 31:2001;1900-1909.
77. Heemskerk M.H.M., Blom B., Nolan G., Stegmann A.P.A., Bakker A.Q., Weijer K., Res P.C.M., Spits H. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186:1997;1597-1602.
78. Anderson K.L., Perkin H., Surh C.D., Venturini S., Maki R.A., Torbett B.E. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J. Immunol. 164:2000;1855-1861.
79. Guerriero A., Langmuir P.B., Spain L.M., Scott E.W. PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood. 95:2000;879-885.
80. ••]. Here, Spi-B is also shown to be expressed normally in the plasmacytoid class of DCs, and its overexpression enhances the generation of these cells from hematopoietic precursors in a permissive culture system. These observations strengthen the link between the normal expression of Spi-B and PU.1, which continues through the early stages of T-cell development, and the ability of these early T-cell precursors to differentiate along the DC pathway.
81. Iwama A., Osawa M., Hirasawa R., Uchiyama N., Kaneko S., Onodera M., Shibuya K., Shibuya A., Vinson C., Tenen D.G., Nakauchi H. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J. Exp. Med. 195:2002;547-558.
82. Bauer S.R., Holmes K.L., Morse H.C. III, Potter M. Clonal relationship of the lymphoblastic cell line P388 to the macrophage cell line P388D1 as evidenced by immunoglobulin gene rearrangements and expression of cell surface antigens. J. Immunol. 136:1986;4695-4699.
83. Principato M., Cleveland J.L., Rapp U.R., Holmes K.L., Pierce J.H., Morse H.C. III, Klinken S.P. Transformation of murine bone marrow cells with combined v-raf-v- myc oncogenes yields clonally related mature B cells and macrophages. Mol. Cell. Biol. 10:1990;3562-3568.
84. + B lymphocytes and macrophages. Immunol. Today. 17:1996;471-475.
85. Res P.C.M., Couwenberg F., Vyth-Dreese F.A., Spits H. Expression of a pTα mRNA in a committed dendritic cell precursor in the human thymus. Blood. 94:1999;2647-2657.
86. Lee C.-K., Kim K., Geiman T.M., Murphy W.J., Muegge K., Durum S.K. Cloning thymic precursor cells: demonstration that individual pro-T1 cells have dual T-NK potential and individual pro-T2 cells have dual αβ-γδ T cell potential. Cell. Immunol. 191:1999;139-144.
87. Shortman K., Vremec D., Corcoran L.M., Georgopoulos K., Lucas K., Wu L. The linkage between T-cell and dendritic cell development in the mouse thymus. Immunol. Rev. 165:1998;39-46.
88. •], the loss of responsiveness coincides with the timing of endogenous PU.1 downregulation. These results emphasize the regulatory instability of precursors during the first stages of lymphoid differentiation, even while the cells are initiating expression of T-cell genes such as pTα.
89. Ohishi K., Varnum-Finney B., Serda R.E., Anasetti C., Bernstein I.D. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood. 98:2001;1402-1407.
90. + stem cells into predendritic cell (Pre-DC)2 but not into Pre-DC1: evidence for a lymphoid origin of Pre-DC2. J. Exp. Med. 192:2000;1775-1783.